![]() CalciMedica CalciMedica (formerly known as Graybug Vision) is a biotechnology company that develops calcium release-activated calcium (CRAC) channel inhibitors. | ![]() Albumedix Albumedix develops bio-therapeutics formulations for advanced drug and vaccine formulation intended to improve therapies for people with serious diseases. | ||
Founding Date | Founding Date 2015 | Founding Date 2007 | Founding Date 2016 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Cleveland, US HQ | Locations La Jolla, US HQ | Locations Nottinghamshire, GB HQ Nottingham, GB |
Employees | Employees 462% increase | Employees 1614% increase | Employees 871% increase |
Financial | |||
Net income | Net income N/A | Net income ($29.6m) (FY, 2025) | Net income £5m (FY, 2018) |
Funding | |||
Total funding raised | Total funding raised $ 6.7m | Total funding raised $ 74.5m | Total funding raised N/A |

CalciMedica (formerly known as Graybug Vision) is a biotechnology company that develops calcium release-activated calcium (CRAC) channel inhibitors.
View company
Albumedix develops bio-therapeutics formulations for advanced drug and vaccine formulation intended to improve therapies for people with serious diseases.
View company